InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Spear Matthew A., Directeur Médical. Director active across 1 company, notably Poseida Therapeutics, Inc.. In total, 7 reports have been recorded. History available since 11 June 2021. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Matthew A. Spear is the Chief Medical Officer at Poseida Therapeutics, Inc. He is responsible for the medical direction of the company, overseeing clinical research and the development of new treatments. His role is essential in ensuring innovation and safety of Poseida's products.